SapVax Company
Developing a suite of first-in-class cancer vaccines based on a novel self-adjuvanting peptide platform technology.
Technology:
Peptides and Proteins
Industry:
Peptides and Proteins
Headquarters:
Cleveland, Ohio, United States
Founded Date:
2016-01-01
Employees Number:
1-10
Total Funding:
3237300
Estimated Revenue:
Less than $1M
Last Funding Date:
2018-01-16
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership